Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 22;24(1):549.
doi: 10.1186/s13063-023-07460-4.

Complex physical therapy employing self-adjusting garment (ReadyWrap®) in breast cancer-related lymphedema cases in Brazilian women: a protocol for a randomized controlled trial

Affiliations

Complex physical therapy employing self-adjusting garment (ReadyWrap®) in breast cancer-related lymphedema cases in Brazilian women: a protocol for a randomized controlled trial

Jéssica Malena Pedro da Silva et al. Trials. .

Abstract

Background: Lymphedema is a common complication following breast cancer treatment. The aim of this study is to evaluate the effectiveness of a self-adjusting compression garment (ReadyWrap®) in reducing (phase 1) and maintaining (phase 2) upper limb volume in women presenting breast cancer-related lymphedema.

Methods: This study will comprise a randomized, controlled, single-blind clinical trial concerning women with breast cancer-related lymphedema undergoing treatment at a public cancer treatment reference hospital in the city of Rio de Janeiro, Brazil. The intervention will be carried out by adapting self-dressing versus the standard treatment of compressive bandaging (phase 1) and compressive mesh (phase 2). Both groups will be assessed at the beginning and end of intensive treatment and followed up for up to 12 months to evaluate immediate and late outcomes. Assessments will be carried out by physical upper limb examination (inspection, palpation, volume, dynamometry, and thermography) and questionnaires application to assess patient's quality of life pertaining to the health, functionality, and symptoms of the affected upper limb, as well adverse effects and adherence to treatment. Data will be analyzed descriptively and analytically through univariate and multiple linear regressions. P values < 0.05 will be considered statistically significant.

Discussion: This study will evaluate the effectiveness of a self-adjustable garment (ReadyWrap®) in the treatment of lymphedema secondary to breast cancer in Brazilian women compared to the gold standard treatment for limb volume reduction (phase 1) and maintenance (phase 2) phases comprising, respectively, a compressive bandaging and a compressive mesh. The outcome results will provide data based on both quantitative responses and self-reported participant outcomes. The study will also assess the cost-effectiveness of the ReadyWrap® treatment versus standard care. Finally, we expect to reaffirm one more product/therapy as a treatment for this extremely complex and impactful condition following the data analysis.

Trial registration: NCT04934098 [Clinical trials phase 1]. Registered on June 22, 2021. NCT04881604 [Clinical trials phase 2]. Registered on May 11, 2021.

Keywords: Breast cancer lymphedema; Compression bandages; Physiotherapy; Rehabilitation medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare a conflict of interest due to the donation of the compressive material used in the study by VENOSAN BRASIL LTDA. Despite this, the company does not present any associations that allow it to favorably change the results of this study to its interests. Therefore, the authors guarantee that they have complete freedom to publish the data.

Figures

Fig. 1
Fig. 1
Study schema

Similar articles

Cited by

References

    1. Rogan S, Taeymans J, Luginbuehl H, Aebi M, Mahnig S, Gebruers N. Therapy modalities to reduce lymphoedema in female breast cancer patients: a systematic review and meta-analysis. Breast Cancer Res Treat. 2016;159(1):1–14. doi: 10.1007/s10549-016-3919-4. - DOI - PubMed
    1. Pereira ACPR, Koifman RJ, Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up. Breast. 2017;36:67–73. doi: 10.1016/j.breast.2017.09.006. - DOI - PubMed
    1. Longhurst E, Dylke ES, Kilbreath SL. Use of compression garments by women with lymphoedema secondary to breast cancer treatment. Support Care Cancer. 2018;26(8):2625–2632. doi: 10.1007/s00520-018-4093-5. - DOI - PubMed
    1. Marchica P, D’arpa S, Magno S, Rossi C, Forcina L, Capizzi V, et al. Integrated treatment of breast cancer-related lymphedema: a descriptive review of the state of the art. Anticancer Res. 2021;41(7):3233–3246. doi: 10.21873/anticanres.15109. - DOI - PubMed
    1. Rockson Lymphedema after breast cancer treatment. N Engl J Med. 2018;379(20):1937–1944. doi: 10.1056/NEJMcp1803290. - DOI - PubMed

Publication types

Associated data